Related Experiment Video
Updated: Aug 11, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Upper airway resistance syndrome: a long-term outcome study
Christian Guilleminault1, Ceyda Kirisoglu, Dalva Poyares
1Stanford Sleep Disorders Clinic, Stanford, CA 94305, USA. cguil@stanford.edu
Journal of Psychiatric Research
|February 14, 2006
Summary
Untreated Upper Airway Resistance Syndrome (UARS) patients experienced worsening insomnia and fatigue over four years. Most patients did not receive CPAP treatment due to insurance denials, leading to increased medication use.
Area of Science:
- Sleep Medicine
- Respiratory Medicine
Background:
- Upper Airway Resistance Syndrome (UARS) is a condition affecting sleep quality.
- Long-term outcomes for UARS patients, particularly regarding treatment and symptom evolution, require further investigation.
Purpose of the Study:
- To assess the symptomatic and polysomnographic changes in Upper Airway Resistance Syndrome patients four and a half years after initial diagnosis.
- To evaluate the impact of non-treatment on UARS patient outcomes.
Main Methods:
- Prospective study involving 94 UARS patients undergoing clinical and polysomnographic re-evaluation.
- Comparison of initial and follow-up polysomnography data.
- Assessment of symptom changes and medication use over approximately 4.5 years.
Main Results:
- None of the 94 patients received CPAP due to insurance denials based on initial AHI.
- Significant increases in daytime fatigue, insomnia, and depressive mood were reported.
- Prescription of hypnotics, antidepressants, and stimulants increased substantially.
- Total sleep time significantly decreased, while respiratory disturbance index showed no significant change.
Conclusions:
- A significant number of UARS patients remain untreated.
- Absence of UARS treatment is associated with a worsening of insomnia, fatigue, and depressive symptoms.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Factors Affecting Pulmonary Ventilation
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
01:24Asthma-III: Symptoms and Complications
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.